Optogenetic Delineation of Receptor Tyrosine Kinase Subcircuits in PC12 Cell Differentiation

John S. Khamo, Vishnu V. Krishnamurthy, Qixin Chen, Jiajie Diao, Kai Zhang

Research output: Contribution to journalArticle

Abstract

Nerve growth factor elicits signaling outcomes by interacting with both its high-affinity receptor, TrkA, and its low-affinity receptor, p75NTR. Although these two receptors can regulate distinct cellular outcomes, they both activate the extracellular-signal-regulated kinase pathway upon nerve growth factor stimulation. To delineate TrkA subcircuits in PC12 cell differentiation, we developed an optogenetic system whereby light was used to specifically activate TrkA signaling in the absence of nerve growth factor. By using tyrosine mutants of the optogenetic TrkA in combination with pathway-specific pharmacological inhibition, we find that Y490 and Y785 each contributes to PC12 cell differentiation through the extracellular-signal-regulated kinase pathway in an additive manner. Optogenetic activation of TrkA eliminates the confounding effect of p75NTR and other potential off-target effects of the ligand. This approach can be generalized for the mechanistic study of other receptor-mediated signaling pathways. Khamo et al. developed a non-neuronal optogenetic system to activate TrkA signaling using blue light. In combination with pharmacological inhibition, the authors delineate the signaling role of key physiological tyrosines in the TrkA intracellular domain. Tyrosines 490 and 785 both induce PC12 cell differentiation through the ERK signaling pathway.

Original languageEnglish (US)
Pages (from-to)400-410.e3
JournalCell chemical biology
Volume26
Issue number3
DOIs
StatePublished - Mar 21 2019

Fingerprint

Optogenetics
PC12 Cells
Receptor Protein-Tyrosine Kinases
Cell Differentiation
Nerve Growth Factor
Tyrosine
Extracellular Signal-Regulated MAP Kinases
trkA Receptor
Pharmacology
Light
MAP Kinase Signaling System
Ligands
Chemical activation

Keywords

  • ERK
  • PC12 cell differentiation
  • PLCγ
  • TrkA signaling subcircuits
  • Y490
  • Y785
  • nerve growth factor
  • optogenetics

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Optogenetic Delineation of Receptor Tyrosine Kinase Subcircuits in PC12 Cell Differentiation. / Khamo, John S.; Krishnamurthy, Vishnu V.; Chen, Qixin; Diao, Jiajie; Zhang, Kai.

In: Cell chemical biology, Vol. 26, No. 3, 21.03.2019, p. 400-410.e3.

Research output: Contribution to journalArticle

Khamo, John S. ; Krishnamurthy, Vishnu V. ; Chen, Qixin ; Diao, Jiajie ; Zhang, Kai. / Optogenetic Delineation of Receptor Tyrosine Kinase Subcircuits in PC12 Cell Differentiation. In: Cell chemical biology. 2019 ; Vol. 26, No. 3. pp. 400-410.e3.
@article{1c6ba648cb8a4ef6b42148879b222c62,
title = "Optogenetic Delineation of Receptor Tyrosine Kinase Subcircuits in PC12 Cell Differentiation",
abstract = "Nerve growth factor elicits signaling outcomes by interacting with both its high-affinity receptor, TrkA, and its low-affinity receptor, p75NTR. Although these two receptors can regulate distinct cellular outcomes, they both activate the extracellular-signal-regulated kinase pathway upon nerve growth factor stimulation. To delineate TrkA subcircuits in PC12 cell differentiation, we developed an optogenetic system whereby light was used to specifically activate TrkA signaling in the absence of nerve growth factor. By using tyrosine mutants of the optogenetic TrkA in combination with pathway-specific pharmacological inhibition, we find that Y490 and Y785 each contributes to PC12 cell differentiation through the extracellular-signal-regulated kinase pathway in an additive manner. Optogenetic activation of TrkA eliminates the confounding effect of p75NTR and other potential off-target effects of the ligand. This approach can be generalized for the mechanistic study of other receptor-mediated signaling pathways. Khamo et al. developed a non-neuronal optogenetic system to activate TrkA signaling using blue light. In combination with pharmacological inhibition, the authors delineate the signaling role of key physiological tyrosines in the TrkA intracellular domain. Tyrosines 490 and 785 both induce PC12 cell differentiation through the ERK signaling pathway.",
keywords = "ERK, PC12 cell differentiation, PLCγ, TrkA signaling subcircuits, Y490, Y785, nerve growth factor, optogenetics",
author = "Khamo, {John S.} and Krishnamurthy, {Vishnu V.} and Qixin Chen and Jiajie Diao and Kai Zhang",
year = "2019",
month = "3",
day = "21",
doi = "10.1016/j.chembiol.2018.11.004",
language = "English (US)",
volume = "26",
pages = "400--410.e3",
journal = "Cell Chemical Biology",
issn = "2451-9448",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Optogenetic Delineation of Receptor Tyrosine Kinase Subcircuits in PC12 Cell Differentiation

AU - Khamo, John S.

AU - Krishnamurthy, Vishnu V.

AU - Chen, Qixin

AU - Diao, Jiajie

AU - Zhang, Kai

PY - 2019/3/21

Y1 - 2019/3/21

N2 - Nerve growth factor elicits signaling outcomes by interacting with both its high-affinity receptor, TrkA, and its low-affinity receptor, p75NTR. Although these two receptors can regulate distinct cellular outcomes, they both activate the extracellular-signal-regulated kinase pathway upon nerve growth factor stimulation. To delineate TrkA subcircuits in PC12 cell differentiation, we developed an optogenetic system whereby light was used to specifically activate TrkA signaling in the absence of nerve growth factor. By using tyrosine mutants of the optogenetic TrkA in combination with pathway-specific pharmacological inhibition, we find that Y490 and Y785 each contributes to PC12 cell differentiation through the extracellular-signal-regulated kinase pathway in an additive manner. Optogenetic activation of TrkA eliminates the confounding effect of p75NTR and other potential off-target effects of the ligand. This approach can be generalized for the mechanistic study of other receptor-mediated signaling pathways. Khamo et al. developed a non-neuronal optogenetic system to activate TrkA signaling using blue light. In combination with pharmacological inhibition, the authors delineate the signaling role of key physiological tyrosines in the TrkA intracellular domain. Tyrosines 490 and 785 both induce PC12 cell differentiation through the ERK signaling pathway.

AB - Nerve growth factor elicits signaling outcomes by interacting with both its high-affinity receptor, TrkA, and its low-affinity receptor, p75NTR. Although these two receptors can regulate distinct cellular outcomes, they both activate the extracellular-signal-regulated kinase pathway upon nerve growth factor stimulation. To delineate TrkA subcircuits in PC12 cell differentiation, we developed an optogenetic system whereby light was used to specifically activate TrkA signaling in the absence of nerve growth factor. By using tyrosine mutants of the optogenetic TrkA in combination with pathway-specific pharmacological inhibition, we find that Y490 and Y785 each contributes to PC12 cell differentiation through the extracellular-signal-regulated kinase pathway in an additive manner. Optogenetic activation of TrkA eliminates the confounding effect of p75NTR and other potential off-target effects of the ligand. This approach can be generalized for the mechanistic study of other receptor-mediated signaling pathways. Khamo et al. developed a non-neuronal optogenetic system to activate TrkA signaling using blue light. In combination with pharmacological inhibition, the authors delineate the signaling role of key physiological tyrosines in the TrkA intracellular domain. Tyrosines 490 and 785 both induce PC12 cell differentiation through the ERK signaling pathway.

KW - ERK

KW - PC12 cell differentiation

KW - PLCγ

KW - TrkA signaling subcircuits

KW - Y490

KW - Y785

KW - nerve growth factor

KW - optogenetics

UR - http://www.scopus.com/inward/record.url?scp=85062892694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062892694&partnerID=8YFLogxK

U2 - 10.1016/j.chembiol.2018.11.004

DO - 10.1016/j.chembiol.2018.11.004

M3 - Article

C2 - 30595532

AN - SCOPUS:85062892694

VL - 26

SP - 400-410.e3

JO - Cell Chemical Biology

JF - Cell Chemical Biology

SN - 2451-9448

IS - 3

ER -